SynthesisCardiovascular therapeutics2023

An Updated Meta-Analysis for Safety Evaluation of Alirocumab and Evolocumab as PCSK9 Inhibitors.

Hye Duck Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.